Cytokine and CXC chemokine expression patterns in aqueous humor of patients with presumed tuberculous uveitis

Cytokine

Volumn 59, Issue 2, 2012, Pages 377-381

  Abu El Asrar, Ahmed M ^a   Struyf, Sofie ^b   Kangave, Dustan ^a   Al Obeidan, Saleh A ^a   Opdenakker, Ghislain ^b   Geboes, Karel ^c   Damme, Jo Van ^b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^c UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Chemokines; Cytokines; Tuberculosis; Uveitis

Indexed keywords

ALPHA CHEMOKINE; CXCL1 CHEMOKINE; CXCL9 CHEMOKINE; CYTOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 4; INTERLEUKIN 8; STROMAL CELL DERIVED FACTOR 1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AQUEOUS HUMOR; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; FEMALE; HUMAN; IMMUNOPATHOGENESIS; MALE; NEUTROPHIL; PRESUMED TUBERCULOUS UVEITIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL; UPREGULATION; UVEITIS;

ADULT; AQUEOUS HUMOR; CASE-CONTROL STUDIES; CHEMOKINES, CXC; CYTOKINES; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; TUBERCULOSIS; UVEITIS; YOUNG ADULT;

EID: 84862314694     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.04.030     Document Type: Article

References (51)

1. Abu El-Asrar A.M., Abouammoh M., Al-Mezaine H.S. Tuberculous uveitis. Int Ophthalmol Clin 2010, 50:19-39.
2. Gupta V., Gupta A., Rao N.A. Intraocular tuberculosis - an update. Surv Ophthalmol 2007, 52:561-587.
3. Al-Mezaine H.S., Kangave D., Abu El-Asrar A.M. Patterns of uveitis in patients admitted to a university hospital in Riyadh, Saudi Arabia. Ocul. Immunol. Inflamm. 2010, 18:424-431.
4. Al-Mezaine H.S., Al-Muammar A., Kangave D., Abu El-Asrar A.M. Clinical and optical coherence tomographic findings and outcome of treatment in patients with presumed tuberculous uveitis. Int Ophthalmol 2008, 28:413-423.
5. Biswas J., Madhavan H.N., Gopal L., Badrinath S.S. Intraocular tuberculosis clinicopathologic study of five cases. Retina 1995, 15:461-468.
6. Rao N.A., Saraswathy S., Smith R.E. Tuberculous uveitis: distribution of Mycobacterium tuberculosis in the retinal pigment epithelium. Arch Ophthalmol 2006, 124:1777-1779.
7. Sundaramurthy V., Pieters J. Interactions of pathogenic mycobacteria with host macrophages. Microbes Infect 2007, 9:1671-1679.
8. Ferrero E., Biswas R., Vettoretto K., Ferrarini M., Uguccioni M., Piali L., et al. Macrophages exposed to Mycobacterium tuberculosis release chemokines able to recruit selected leucocyte subpopulations: focus on γδ cells. Immunology 2003, 108:365-374.
9. Flynn J.L., Chan J., Triebold K.J., Dalton D.K., Stewart T.A., Bloom B.R. An essential role for interferon-gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 1993, 178:2249-2254.
10. Fulton S.A., Johnsen J.M., Wolf S.F., Sieburth D.S., Boom W.H. Interleukin-12 production by human monocytes infected with Mycobacterium tuberculosis: role of phagocytosis. Infect Immun 1996, 64:2523-2531.
11. Appelberg R. Protective role of interferon gamma, tumor necrosis factor alpha and interleukin-6 in Mycobacterium tuberculosis and M. avium infections. Immunobiology 1994, 191:520-525.
12. Cooper A.M., Magram J., Ferrante J., Orme I.M. Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis. J Exp Med 1997, 186:39-45.
13. Mosmann T.R., Coffman R.L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989, 7:145-173.
14. Okamoto M., Kawabe T., Iwasaki Y., Hara T., Hashimoto N., Imaizumi K., et al. Evaluation of interferon-gamma, interferon-gamma-inducing cytokines, and interferon-gamma-inducible chemokines in tuberculous pleural effusions. J Lab Clin Med 2005, 145:88-93.
15. Supriya P., Candrasekaran P., Das S.D. Diagnostic utility of 10kDa (IP-10) in tuberculous pleurisy. Diagn Microbiol Infect Dis 2008, 62:186-192.
16. Hiraki A., Aoe K., Matsuo K., Murakami K., Murakami T., Onoda T., et al. Simultaneous measurement of T-helper1 cytokines in tuberculous pleural effusion. Int. J. Tuberc. Lung Dis. 2003, 7:1172-1177.
17. Jiang J., Shi H.Z., Liang Q.L., Qin S.M., Qin X.J. Diagnostic value of interferon-γ in tuberculous pleurisy A metaanalysis. Chest 2007, 131:1133-1141.
18. Barnes P.F., Lu S., Abrams J.S., Wang E., Yamamura M., Modin R.L. Cytokine production at the site of disease in human tuberculosis. Infect Immun 1993, 61:3482-3489.
19. Lin Y., Zhang M., Hofman F.M., Gong J., Barnes P.F. Absence of a prominent Th2 cytokine response in human tuberculosis. Infect Immun 1996, 64:1351-1356.
20. Robinson D.S., Ying S., Taylor I.K., Wangoo A., Mitchell D.M., Kay A.B., et al. Evidence for a Th1-like bronchoalveolar T-cell subset and predominance of interferon-gamma gene activation in pulmonary tuberculosis. Am J Respir Crit Care Med 1994, 149:989-993.
21. Fuller C.L., Flynn J.L., Reinhart T.A. In situ study of abundant expression of proinflammatory chemokines and cytokines in pulmonary granulomas that develop in cynomolgus macaques experimentally infected with Mycobacterium tuberculosis. Infect Immun 2003, 71:7023-7034.
22. Verbon A., Juffermans N., Van Deventer S.J.H., Speelman P., Van Deutekom H. Serum concentrations of cytokines in patients with active tuberculosis (TB) and after treatment. Clin Exp Immunol 1999, 115:110-113.
23. Deveci F., Akbulut H.H., Turgut T., Muz M.H. Changes in serum cytokine levels in active tuberculosis with treatment. Mediators Inflamm 2005, 5:256-262.
24. Vankayalapati R., Wizel B., Weis S.E., Klucar P., Shams H., Samten B., et al. Serum cytokine concentrations do not parallel Mycobacterium tuberculosis-induced cytokine production in patients with tuberculosis. Clin Infect Dis 2003, 36:24-28.
25. Dlugovitzky D., Bay M.L., Rateni L., Urizar L., Rondelli C.F., Largacha C., et al. In vivo synthesis of interferon-gamma, interleukin-4, transforming growth factor-beta and interleukin-1 beta by peripheral blood mononuclear cells from tuberculosis patients: relationship with the severity of pulmonary involvement. Scand J Immunol 1999, 49:210-217.
26. Harris J., De Haro S.A., Master S.S., Keane J., Roberts E.A., Delgado M., et al. T helper 2 cytokines inhibit autophagic control of intracellular Mycobacterium tuberculosis. Immunity 2007, 27:505-517.
27. +effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005, 6:1123-1132.
28. Park H., Li Z., Yang X.O., Chang S.H., Nurieva R., Wang Y.H., et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005, 6:1133-1141.
29. Cruz A., Khader S.A., Torrado E., Fraga A., Pearl J.E., Pedrosa J., et al. Cutting edge: IFN-γ regulates the induction and expansion of IL-17-producing CD4 T cells during mycobacterial infection. J Immunol 2006, 177:1416-1420.
30. Lockhart E., Green A.M., Flynn J.L. IL-17 production is dominated by γδ T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. J Immunol 2006, 177:4662-4669.
31. Yoshida Y.O., Umemura M., Yahagi A., O'Brien R.L., Ikuta K., Kishihara K., et al. Essential role of IL-17A in the formation of a mycobacterial infection-induced granuloma in the lung. J Immunol 2010, 184:4414-4422.
32. Wang T., Lv M., Qian Q., Nie Y., Yu L., Hou Y. Increased frequencies of T helper type 17 cells in tuberculous pleural effusion. Tuberculosis 2011, 91:231-237.
33. Struyf S., Proost P., Van Damme J. Regulation of the immune response by the interaction of chemokines and proteases. Adv Immunol 2003, 81:1-44.
34. Murphy P.M., Baggiolini M., Charo I.F., Hebert C.A., Horuk R., Matsushima K., et al. International Union of Pharmacology, XXII. Nomenclature for chemokine receptors. Pharmacol Rev 2000, 52:145-176.
35. Jabs D.A., Nussenblatt R.B., Rosenbaum J.T. Standardization of Uveitis Nomenclature (SUN) working group standardization of uveitis nomenclature for reporting clinical data: results of the first international workshop. Am J Ophthalmol 2005, 140:509-516.
36. Song C.H., Kim H.J., Park J.K., Lim J.H., Kim U.O., Kim J.S., et al. Depressed interleukin-12 (IL-12), but not IL-18, production in response to a 30- or 32-kilodalton mycobacterial antigen in patients with active pulmonary tuberculosis. Infect Immun 2000, 68:4477-4484.
37. Fehniger T.A., Caligiuri M.A. Interleukin 15: biology and relevance to human disease. Blood 2001, 97:14-32.
38. Waldmann T.A. Targeting the interleukin-15/interleukin-15 receptor system in inflammatory autoimmune disease. Arthritis Res Ther 2004, 6:174-177.
39. Abebe F., Mustafa T., Nerland A.H., Bjune G.A. Cytokine profile during latent and slowly progressive primary tuberculosis: a possible role for interleukin-15 in mediating clinical disease. Clin Exp Immunol 2005, 143:180-192.
40. Muro S., Taha R., Asicopoulos A., Olivenstein R., Tonnel A.B., Christodoulopoulos P., et al. Expression of IL-15 in inflammatory pulmonary diseases. J Allergy Clin Immunol 2001, 108:970-975.
41. 17 cells. Nature 2008, 453:1051-1057.
42. Asadullah K., Sterry W., Volk H.D. Interleukin-10 therapy. Review of a new approach. Pharmacol Rev 2003, 55:241-269.
43. +Tregs: limiting collateral damage. J Clin Invest 2004, 114:1372-1378.
44. Whittaker E., Gordon A., Kampmann B. Is IP-10 a better biomarker for active and latent tuberculosis in children than IFN-γ?. PLoS ONE 2008, 3:e3901.
45. Azzurri A., Sow O.Y., Amedia A., Bah B., Diallo S., Peri G., et al. IFN-gamma-inducible protein 10 and pentrazin 3 plasma levels are tools for monitoring inflammation and disease activity in Mycobacterium tuberculosis infection. Microbes Infect. 2005, 7:1-8.
46. Ruhwald M., Dominguez J., Latorre I., Losi M., Richeldi L., Pasticci M.B., et al. A multicenter evaluation of the accuracy and performance of IP-10 for the diagnosis of infection with M. tuberculosis. Tuberculosis 2011, 91:260-267.
47. Lacotte S., Brun S., Muller S., Dumortier H. CXCR3, inflammation, and autoimmune diseases. Ann NY Acad Sci 2009, 1173:310-317.
48. Gouwy M., Struyf S., Proost P., Van Damme J. Synergy in cytokine and chemokine networks amplifies the inflammatory response. Cytokine Growth Factor Rev 2005, 16:561-580.
49. Seiler P., Aichele P., Bandermann S., Hauser A.E., Lu B., Gerard N.P., et al. Early granuloma formation after aerosol Mycobacterium tuberculosis infection is regulated by neutrophils via CXCR3-signaling chemokines. Eur J Immunol 2003, 33:2676-2686.
50. Wang C., Peyron P., Mestre O., Kaplan G., van Soolingen D., Gao Q., et al. Innate immune response to Mycobacterium tuberculosis Beijing and other genotypes. PLoS ONE 2010, 5:e13594.
51. Riedel D.D., Kaufmann S.H.E. Chemokine secretion by human polymorphonuclear granulocytes after stimulation with Mycobacterium tuberculosis and lipoarabinomannan. Infect Immun 1997, 65:4620-4623.